陇神戎发：公司将持续聚焦主业

Core Viewpoint - The company will continue to focus on its main business and leverage the advantages of state-owned capital to strengthen its market presence and expand into OTC and untapped areas [1] Group 1: Business Strategy - The company is concentrating on two exclusive core products: Yuanhu Zhitong Pill and Xuanfei Zhiso Mixture, aiming to consolidate its existing market [1] - The company plans to actively expand into the generic drug market, health products line, and medical devices to cultivate new growth points [1] Group 2: Research and Development - The company is committed to increasing R&D investment and enhancing its R&D capabilities, aiming to build a collaborative innovation system and a long-term mechanism for R&D investment [1] - The company will continue to promote the secondary development of its main products while increasing R&D efforts in new drugs, classic formulas, and health-related fields to enrich its product pipeline and enhance core competitiveness [1]